DLL3 and neoplasm: In two of three patients (patients 5 and 6; Figs 4A and 4B, Data Supplement, Fig S6B), DLL3 immunoPET-CT imaging revealed that all individual DLL3 PET-positive tumor lesions also demonstrated SSTR avidity on corresponding 68Ga-DOTATATE PET-CT imaging.